|

Editor-in-Chief:
Vladimir P. Torchilin
Department of Pharmaceutical Science
Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
USA
Regional Editors:
Detlev Boison
RS Dow Neurobiology Laboratories
Portland, OR
USA
Grzegorz Bazylak
Nicolaus Copernicus University
Bydgoszcz
Poland
Martin Braddock
AstraZeneca Research and Development
Leicestershire
UK
Eduardo A. Castro
INIFTA, Theoretical Chemistry Division
La Plata, Buenos Aires
Argentina
Yiyun Cheng
East China Normal University
Shanghai
China
Section Editor:
Section: Environmental Endocrinology
M. Ishido
National Institute for Environmental Studies
Tsukuba
Japan
Editorial Advisory Board:
M. Abdollahi (Tehran University
of Medical Sciences, Tehran, Iran)
B.B. Aggarwal (University of Texas MD Anderson Cancer Center, Houston, TX,
USA)
C. Ahlberg (Spotfire, Inc., Somerville, MA, USA)
G.D. Armstrong (University of Calgary, Calgary,
Alberta, Canada)
A.M. Aronov (Vertex Pharmaceuticals, Inc.,
Cambridge, MA, USA)
Y. Audigier (Institute of Molecular Medecine
of Rangueil, U858 INSERM, France)
D.L. Banville (AstraZeneca Pharmaceuticals,
Wilmington, DE, USA)
J. Bayry (Centre de Recherche des Cordeliers,
Paris, France)
S.J. Benkovic (The Pennsylvania State University, University Park, PA, USA)
C.R. Bramham (University of Bergen, Bergen,
Norway)
S. Brase (University of Karlsruhe, Karlsruhe,
Germany)
R. Breslow (Columbia University, New York, NY, USA)
M.H. Bronchud (Hospital General of Granollers,
Barcelona, Spain)
M.B. Brown (University of Hertfordshire,
Herts, UK)
R. Bucala (Yale University School of Medicine,
New Haven, CT, USA)
G.L. Challis (University of Warwick, Coventry,
UK)
K.K. Chan (The Ohio State University, Ohio,
OH, USA)
J.P.F. Chin-Dusting (Baker Heart Research
Institute, Melbourne, Australia)
P. Colas (Station Biologique, Place Georges
Teissier, Roscoff, France)
R.A. Copeland (GlaxoSmithKline, Collegeville,
PA, USA)
R. Cortesi (Ferrara University, Ferrara,
Italy)
M. Crawford (Cerep, Inc., Auburn, WA, USA)
M. Cristofanilli (The University of Texas,
Houston, TX, USA)
J.-V. De Julian Ortiz (Polytechnic University
of Valencia, Valencia, Spain)
X. Deng (Emory University School of Medicine,
Atlanta, GA, USA)
M.M. De Villiers (University of Wisconsin,
Madison, WI, USA)
U.M.G. Döbbeling (University Hospital
Zurich, Zurich, Switzerland)
J. Drews (Bear Stearns Health Innoventure,
New York, NY, USA)
T.L. Dunckley (Translational Genomics Research
Institute, Phoenix, AZ, USA)
E. Estrada (University of Santiago de Compostela,
Santiago de Compostela, Spain)
Y. Fang (Corning Inc., Corning, NY, USA)
M. Feher (The Campbell Family Institute for
Breast Cancer Research, Toronto, ON, Canada)
W.Y. Feng (Bridge Pharmaceuticals, Beijing,
China)
D.R. Flower (University of Oxford, Berkshire,
UK)
A. Fura (Bristol-Myers Squibb R&D, Princeton,
NJ, USA)
Z.-G. Gao (National Institutes of Health,
Bethesda, MD, USA)
G. Gardiner (Yale University, New Haven, CT, USA)
L. Ghosez (European Institute of Chemistry and Biology, Cedex, France)
J.C. Glorioso (University of Pittsburgh,
Pittsburgh, PA, USA)
B. Gold (National Cancer Institute, Frederick,
MD, USA)
J.A. Grosso (Bristol-Myers Squibb R&D,
Princeton, NJ, USA)
C.P. Hart (Threshold Pharmaceuticals, Redwood
City, CA, USA)
A. Hillisch (Bayer HealthCare AG, Wuppertal,
Germany) A.G. Horti (Johns Hopkins University, Baltimore, MD, USA)
K. Houk (University of California, Los Angeles, CA, USA)
J. Huard (University of Pittsburgh, Pittsburgh,
PA, USA)
D.W. Hutmacher (National University of Singapore,
Singapore, Singapore)
K. Islam (Arpida, Switzerland)
J.W. Janetka (AstraZeneca R&D Boston,
Waltham, MA, USA)
Z.L. Ji (Xiamen University, Fujian, China)
J. Kardos (Hungarian Academy of Sciences,
Budapest, Hungary)
K. Kariko (University of Pennsylvania School
of Medicine, Philadelphia, PA, USA)
S. Klussmann (Noxxon Pharma AG, Berlin, Germany)
M. Komada (Tokyo Institute of Technology,
Yokohama, Japan)
W.A. Korfmacher (Schering-Plough Research
Institute, Kenilworth, NJ, USA)
T.A. Kost (GlaxoSmithKline, Research Triangle
Park, NC, USA)
M.S. Lajiness (Eli Lilly and Company, Corporate
Circle, Indianapolis, IN, USA)
J.M. Lehn (Nobel Laureate Institut Le Bel, Cedex, France)
J.-P. Leonetti (Centre de Pharmacologie et
Biotechnologie pour la Sante, Montpeillier, France)
C. Lipinski (Pfizer Global R&D, Waterford, CT, USA)
S.A. Lipton (Burnham Institute for Medical
Research, La Jolla, CA, USA)
S. Liu (Schering-Plough Research Institute,
Kenilworth, NJ, USA)
E. Lolis (Yale University, New Haven, CT,
USA)
K. Maggon (Pharma Biotech R&D, Geneva, Switzerland)
C.R. Martin (University of Florida, Gainesville,
FL, USA)
N. Maulik (University of Connecticut School
of Medicine, Farmington, CT, USA)
L.K. Minor (Johnson & Johnson Pharmaceutical
R&D, Spring House, PA, USA)
L. Mitscher (University of Kansas, Lawrence, KS, USA)
S.M. Moghimi (University of Copenhagen, Copenhagen, Denmark)
M. Moloney (University of Oxford, Oxford, UK)
R. Morphy (Organon Laboratories Ltd., Motherwell,
UK)
K. Mueller (Hoffman-La Roche Ltd., Basel, Switzerland)
D.J. Muller (University of Technology Dresden,
Dresden, Germany)
M. Murcko (Independent Consultant, Holliston, MA, USA)
J.P. O'Bryan (University of Illinois College
of Medicine, Chicago, IL, USA)
T. Ochiya (National Cancer Center Research
Institute, Tokyo, Japan)
H. Onishi (Hoshi University, Tokyo, Japan)
E. Paleolog (Imperial College, London, UK)
K.H. Pearce (GlaxoSmithKline, Research Triangle
Park, NC, USA)
R.T. Peterson (Massachusetts General Hospital,
Charlestown, MA, USA)
G. Poda (Ontario Institute for Cancer Research, Toronto, ON, Canada)
Y.G. Pommier (National Institutes of Health,
Bethesda, MD, USA)
J.Z. Qin (Loyola University Chicago, Maywood,
IL, USA)
I.N. Rich (HemoGenix, Inc., Colorado Springs,
CO, USA)
D.D. Root (University of North Texas, Denton,
TX, USA)
A.P. Russ (University of Oxford, Oxford,
UK)
M. Ruvo (University of Naples, Napoli, Italy)
R. Roy (Pharmaqam, Montreal (QC), Canada)
D.K. Sarker (University of Brighton, Brighton,
UK)
J. Schlessinger (Yale University, New Haven, CT, USA)
V. Shanmugasundaram (Pfizer PharmaTherapeutics
Research & Development, Groton, CT, USA) K.B. Sharpless (The Scripps Research Institute (TSRI), La Jolla, CA, USA)
P.J. Sinko (Rutgers University,
Piscataway, NJ, USA)
C.P. Sosa (University of Minnesota, Minneapolis,
MN, USA)
M. Spedding (Institute of Research Servier,
Suresnes, France)
L. Stewart (deCODE biostructures Inc., Bainbridge
Island, WA, USA)
G. Subramanian (Sanofi-aventis, New Jersey,
NJ, USA)
K. Sugahara (Hokkaido University Graduate
School of Life Science, Hokkaido, Japan)
D.R. Taft (Long Island University, Brooklyn,
NY, USA)
Y. Takei (Nagoya University, Nagoya, Japan)
P. Talaga (UCB Chemin du Foriest, Braine-l'Alleud,
Belgium)
I.V. Tetko (Institute for Bioinformatics,
Neuherberg, Germany)
A.A. Toropov (Institute of Geology &
Geophysics of Academy Science, Tashkent, Republic Uzbekistan)
F. Torrens (University of Valencia, Valencia,
Spain)
G. Trainor (Bristol-Myers Squibb Pharmaceutical, Delaware,
USA)
S.M. Turner (KineMed, Inc., Emeryville, CA,
USA)
J. Vaidyanathan (University of Medicine and
Dentistry of NJ, Newark, NJ, USA)
M.A. Walker (Bristol-Myers Squibb R&D,
Wallingford, CT, USA)
J.J. Wang (Wyeth Pharmaceuticals, Collegeville, PA, USA)
P.A. Wender (Stanford University, Stanford, CA, USA)
L.C. Wienkers (Amgen Inc., Seattle, WA, USA)
M.S. Wolfe (Harvard Medical School, Boston,
MA, USA)
S. Yamagishi (Kurume University School of
Medicine, Kurume, Japan)
A.K. Yudin (University of Toronto, Toronto,
Ontario, Canada)
Y. Zhang (Johns Hopkins University, Baltimore,
MD, USA)
X.F.S. Zheng (UMDNJ-Robert Wood Johnson Medical
School, Piscataway, NJ, USA)
J. Zhou (University of Texas, Galveston,
TX, USA)
|